Kilitch Drugs (India) has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavin Mukund Mehta.
The above information is a part of company’s filings submitted to BSE.